SYK - Insider Move: Allan C Golston Exercises Options Realizing $1.11M At Stryker | Benzinga
Allan C Golston, Director at Stryker (NYSE:SYK), reported a large exercise of company stock options on February 6, according to a new SEC filing.
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Golston, Director at Stryker, executed a strategic derivative sale. This involved exercising stock options for 4,570 shares of SYK, resulting in a transaction value of $1,111,104.
Currently, Stryker shares are trading down 0.06%, priced at $339.56 during Wednesday's morning. This values Golston's 4,570 shares at $1,111,104.
Delving into Stryker's Background
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Stryker: Financial Performance Dissected
Revenue Growth: Over the 3 months period, Stryker showcased positive performance, achieving a revenue growth rate of 18.46% as of 31 December, 2023. This reflects a ...